Zota Health Care Acquires Shares in Curexis Ventures to Expand SKIA Store Network
Zota Health Care Limited has acquired 1,000,000 equity shares of M/s Curexis Ventures Private Limited, a Wholly Owned Subsidiary of the Company, through the subscription to a right issue.The acquisition was completed on June 22, 2026. Zota Health Care stated that this investment in Curexis is part of a strategic move intended for expanding its SKIA stores and mitigating working capital requirements for the subsidiary. Following this transaction, Curexis remains a Wholly Owned Subsidiary of Zota Health Care Limited.
Details of the Target Entity
Curexis Ventures Private Limited is established as a drug manufacturing, development, and marketing company. It operates retail pharmacy stores under the brand name 'SKIA', offering various Pharmaceutical, Nutraceutical, Cosmetic, Ayurvedic, and OTC products.As per audited financial statements for the Financial Year 2025-26, Curexis recorded a turnover of Rs. 1.18 Lakhs, with total paid up share capital amounting to Rs. 1 Lakh. The industry for Curexis is Pharmaceutical.
Acquisition Terms and Cost
The acquisition involved a cash consideration by acquiring equity shares. Zota Health Care acquired the 1,000,000 equity shares at a cost of Rs. 20.00 per equity share, which included a premium of Rs. 10.00 per equity share. This transaction aggregated to a total cost of Rs. 2,00,00,000.00.The Company acquired all the shares, ensuring that Curexis remains a Wholly-owned Subsidiary. The acquisition does not fall within related party transactions, and the promoter or promoter group has no interest in the entity being acquired; the transaction was conducted at arm's length basis.
Financial Overview of Curexis Ventures Private Limited
The table below provides details regarding the background and financial performance of Curexis during its initial years of operation.| Particulars | Details |
|---|---|
| Incorporation Date | February 25, 2025 |
| Primary Business | Drug manufacturing, development, and marketing in retail pharmacy stores under the 'SKIA' brand |
| FY 2025-26 Turnover | Rs. 1.18 Lakhs |
| FY 2024-25 Turnover | NIL |
| FY 2023-24 Turnover | N.A. |
The acquisition is set to further support the expansion of SKIA stores, making it a strategic move for Zota Health Care Limited in the pharmaceutical sector.
ZOTA Stock Price Movement
Today, shares of Zota Health Care Limited rallied through the trading session, gaining 5.31% to settle at ₹1377 after adding a significant ₹69.40 to its value. The stock experienced robust activity, with a total traded volume of 116,285 shares as it moved within an intraday range stretching from ₹1292 to the closing high.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.